Holden Comprehensive Cancer Center at the University of Iowa — Iowa City, Iowa

Holden Comprehensive Cancer Center at the University of Iowa is a clinical research site located in Iowa City, Iowa, United States 52242.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Holden Comprehensive Cancer Center at the University of Iowa has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma.

Sponsors: Caribou Biosciences, Inc., University of Iowa, Joseph J. Cullen, MD, FACS.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Holden Comprehensive Cancer Center at the University of Iowa?

Holden Comprehensive Cancer Center at the University of Iowa has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Holden Comprehensive Cancer Center at the University of Iowa conducted?

Holden Comprehensive Cancer Center at the University of Iowa has 5 clinical trials on record, with 3 currently active. Their work covers Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma.

Is Holden Comprehensive Cancer Center at the University of Iowa accredited by Crixeo Health?

Yes — Holden Comprehensive Cancer Center at the University of Iowa holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Holden Comprehensive Cancer Center at the University of Iowa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.